Evidence map›Paper›PMID 41645247›Full record

ArticleRespiratory research2026

CXCL11 levels regulate lung Treg responses to deter the onset of HIV-related COPD.

Abdoulaye J Dabo, Patrick Geraghty, Oleg Evgrafov, Michael Campos, Eran Hadas, Boe-Hyun Kim, Mary J Potash, David J Volsky, Robert F Foronjy

Abstract read
In one paragraph

Article in Respiratory research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Abdoulaye J DaboDivision of Pulmonary & Critical Care Medicine, Department of Medicine, State University of New York Downstate Health Sciences University, Brooklyn, NY, USA.
Patrick GeraghtyDivision of Pulmonary & Critical Care Medicine, Department of Medicine, State University of New York Downstate Health Sciences University, Brooklyn, NY, USA.
Oleg EvgrafovDepartment of Cell Biology, State University of New York Downstate Health Sciences University, Brooklyn, NY, USA.
Michael CamposDivision of Pulmonary and Critical Care Medicine, Department of Medicine, The University of Miami Miller School of Medicine, Florida, Miami, USA.
Eran HadasMolecular Virology Division, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Boe-Hyun KimMolecular Virology Division, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Mary J PotashMolecular Virology Division, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
David J VolskyMolecular Virology Division, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Robert F ForonjyDivision of Pulmonary & Critical Care Medicine, Department of Medicine, State University of New York Downstate Health Sciences University, Brooklyn, NY, USA. robert.foronjy@downstate.edu.

Funding

Alpha-1 Foundation 493373Flight Attendant Medical Research Institute CIA160005Flight Attendant Medical Research Institute CIA160028NHLBI NIH HHS R01 HL162590-01A1
6 · The paper itself

Abstract

backgroundInflammation drives COPD development in people living with HIV (PLwHIV), and the HIV virus impairs T regulatory (Treg) cell responses that deter immune-mediated lung injury. This study sought to determine how cigarette smoke exposure alters lung Treg responses to increase COPD susceptibility in PLwHIV.

methodsLung lavage levels of the Treg chemoattractant CXCL11 were quantified in a cohort of 26 HIV-infected subjects and 34 age-matched controls. To ascertain how CXCL11 modifies lung Treg responses, analyses were then conducted using a chimeric HIV (EcoHIV) infection smoke exposure mouse model and elastase treatment of Treg depleted (DEREG) mice.

resultsCXCL11 lung lavage levels increased in HIV + subjects compared to controls. However, CXCL11 levels were significantly lower in those HIV + subjects with a reduced diffusing capacity for carbon monoxide compared to HIV + subjects with normal lung function. Cigarette smoke exposure reduced CXCL11 levels in HIV + current smokers and decreased lung Cxcl11 levels and Treg frequency in control and EcoHIV-infected mice. Cigarette smoke increased lung c-Src activity in mice and the c-Src inhibitor AZD0530 restored Cxcl11 expression in smoke exposed mice and alveolar macrophages. Direct administration of CXCL11 protein to the airways of EcoHIV infected or smoke exposed mice significantly enhanced lung Treg responses. Treg deficient DEREG mice exhibited increased airway resistance at baseline and had greater lung tissue destruction post elastase treatment.

conclusionsThese findings indicate that cigarette smoke activates c-Src to suppress CXCL11 levels thereby diminishing lung Treg responses that counter airways disease and lung tissue destruction in HIV-infected individuals.

Indexed as

Chemokine CXCL11HIV InfectionsLungPulmonary Disease, Chronic ObstructiveT-Lymphocytes, RegulatoryAdultAnimalsFemaleHumansMaleMiceMice, Inbred C57BLMiddle AgedChemokine CXCL11CXCL11 protein, humanCellular src kinaseChronic obstructive pulmonary diseaseCigarette smokeCXCL11InflammationTreg

Identifiers

PMID41645247
PMCPMC12973723

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.